IL-6 gene promoter polymorphisms and risk of coronary artery disease in a Chinese population

Genetics and Molecular Research

Volumn 13, Issue 3, 2014, Pages 7718-7724

  Sun, G Q ^a   Wu, G D ^a   Meng, Y ^b   Du, B ^a   Li, Y B ^c  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

^c Changchun Medical College   (China)

Author keywords

Case control study; Chinese population; Coronary artery disease; Interleukin 6

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHINESE; CHOLESTEROL BLOOD LEVEL; CODOMINANCE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOMINANT INHERITANCE; FEMALE; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC RISK; GENOTYPE; HUMAN; HYPERTENSION; IL 6 GENE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROMOTER REGION; RECESSIVE INHERITANCE; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE; AGED; CHINA; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS;

AGED; CHINA; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84907829286     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.September.26.9     Document Type: Article

References (21)

1. Anderson DR, Poterucha JT, Mikuls TR, Duryee MJ, et al. (2013). IL-6 and its receptors in coronary artery disease and acute myocardial infarction. Cytokine 62: 395-400.
2. Chen Z, Qian Q, Tang C, Ding J, et al. (2013). Association of two variants in the interleukin-6 receptor gene and premature coronary heart disease in a Chinese Han population. Mol. Biol. Rep. 40: 1021-1026.
3. Ghazouani L, Abboud N, Ben Hadj KS, Added F, et al. (2011). -174G>C interleukin-6 gene polymorphism in Tunisian patients with coronary artery disease. Ann. Saudi Med. 31: 40-44.
4. Hansson GK (2005). Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352: 1685-1695.
5. Kim YR, Park JH, Lee HJ, Pyun WB, et al. (2012). The effect of doubling the statin dose on pro-inflammatory cytokine in patients with triple-vessel coronary artery disease. Korean Circ. J. 42: 595-599.
6. Kroeger CM, Klempel MC, Bhutani S, Trepanowski JF, et al. (2012). Improvement in coronary heart disease risk factors during an intermittent fasting/calorie restriction regimen: Relationship to adipokine modulations. Nutr. Metab. 9: 98.
7. LaFramboise WA, Dhir R, Kelly LA, Petrosko P, et al. (2012). Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography. BMC Med. 10: 157.
8. Li Z, Jin D, Wu Y, Zhang K, et al. (2012). Increased serum interleukin-34 in patients with coronary artery disease. J. Int. Med. Res. 40: 1866-1870.
9. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, et al. (2010). Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: e46-e215.
10. Mehta JL, Saldeen TG and Rand K (1998). Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J. Am. Coll. Cardiol. 31: 1217-1225.
11. Nabata T, Morimoto S, Koh E, Shiraishi T, et al. (1990). Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. Biochem. Int. 20: 445-453.
12. Paoletti R, Gotto AM Jr and Hajjar DP (2004). Inflammation in atherosclerosis and implications for therapy. Circulation 109: III20-III26.
13. Phulukdaree A, Khan S, Ramkaran P, Govender R, et al. (2013). The interleukin-6 -147 g/c polymorphism is associated with increased risk of coronary artery disease in young South African Indian men. Metab. Syndr. Relat. Disord. 11: 205-209.
14. Rasmussen L, Delabio R, Horiguchi L, Mizumoto I, et al. (2013). Association between interleukin 6 gene haplotype and Alzheimer’s disease: a Brazilian case-control study. J. Alzheimers Dis. 36: 733-738.
15. Ross R (1999). Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340: 115-126.
16. Sekuri C, Cam FS, Sagcan A, Ercan E, et al. (2007). No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort. Coron. Artery Dis. 18: 333-337.
17. Shi TY, Zhu ML, He J, Wang MY, et al. (2013). Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women. Hum. Genet. 132: 301-312.
18. Su D, Li Z, Li X, Chen Y, et al. (2013). Association between serum interleukin-6 concentration and mortality in patients with coronary artery disease. Mediators Inflamm. 2013: 726178.
19. Xie F, Qian Q, Chen Z, Ma G, et al. (2012). Chitinase 3-like 1 gene-329G/A polymorphism, plasma concentration and risk of coronary heart disease in a Chinese population. Gene 499: 135-138.
20. Yang Y, Zhang F, Skrip L, Lei H, et al. (2013). IL-6 gene polymorphisms and CAD risk: a meta-analysis. Mol. Biol. Rep. 40: 2589-2598.
21. Yudkin JS, Stehouwer CD, Emeis JJ and Coppack SW (1999). C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19: 972-978.